Open AccessThis article is
- freely available
Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma
Clinical Cooperation Unit of Molecular Gastroenterology, DKFZ, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Functional Proteome Analysis, DKFZ, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Department of Surgical Gastroenterology, CLINTEC, K53, Karolinska Institute, SE-14186 Stockholm, Sweden
Department of Medicine II, Medical Faculty of Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany
* Author to whom correspondence should be addressed.
Received: 1 December 2010; in revised form: 10 December 2010 / Accepted: 24 December 2010 / Published: 30 December 2010
Abstract: Pancreatic cancer ranks among the tumors most resistant to chemotherapy. Such chemoresistance of tumors can be mediated by various cellular mechanisms including dysregulated apoptosis or ineffective drug concentration at the intracellular target sites. In this review, we highlight recent advances in experimental chemotherapy underlining the role of cellular transporters in drug resistance. Such contribution to the chemoresistant phenotype of tumor cells or tissues can be conferred both by uptake and export transporters, as demonstrated by in vivo and in vitro data. Our studies used human pancreatic carcinoma cells, cells stably transfected with human transporter cDNAs, or cells in which a specific transporter was knocked down by RNA interference. We have previously shown that 5-fluorouracil treatment affects the expression profile of relevant cellular transporters including multidrug resistance proteins (MRPs), and that MRP5 (ABCC5) influences chemoresistance of these tumor cells. Similarly, cell treatment with the nucleoside drug gemcitabine or a combination of chemotherapeutic drugs can variably influence the expression pattern and relative amount of uptake and export transporters in pancreatic carcinoma cells or select for pre-existing subpopulations. In addition, cytotoxicity studies with MRP5-overexpressing or MRP5-silenced cells demonstrate a contribution of MRP5 also to gemcitabine resistance. These data may lead to improved strategies of future chemotherapy regimens using gemcitabine and/or 5-fluorouracil.
Keywords: ABC transporters; chemoresistance; pancreatic cancer; gemcitabine;
5-fluorouracil; multidrug resistance proteins; S100A4; OATPs; nucleoside transporters; RNA interference
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Hagmann, W.; Faissner, R.; Schnölzer, M.; Löhr, M.; Jesnowski, R. Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma. Cancers 2011, 3, 106-125.
Hagmann W, Faissner R, Schnölzer M, Löhr M, Jesnowski R. Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma. Cancers. 2011; 3(1):106-125.
Hagmann, Wolfgang; Faissner, Ralf; Schnölzer, Martina; Löhr, Matthias; Jesnowski, Ralf. 2011. "Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma." Cancers 3, no. 1: 106-125.